DECONGESTION STRATEGIES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN ACUTE HEART FAILURE

[1]  K. Swedberg,et al.  Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. , 2013, European heart journal.

[2]  E. Braunwald,et al.  Heart failure. , 2013, JACC. Heart failure.

[3]  K. Anstrom,et al.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome. , 2012, The New England journal of medicine.

[4]  C. O'connor,et al.  Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. , 2012, American heart journal.

[5]  C. Ronco,et al.  Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. , 2012, Journal of the American College of Cardiology.

[6]  G. Felker,et al.  Diuretics and ultrafiltration in acute decompensated heart failure. , 2012, Journal of the American College of Cardiology.

[7]  C. O'connor,et al.  Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. , 2012, Journal of cardiac failure.

[8]  S. Werns.  Diuretic Strategies in Patients with Acute Decompensated Heart Failure , 2012 .

[9]  G. Gensini,et al.  Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study , 2011, European journal of heart failure.

[10]  Y. Hori,et al.  Differences in the duration of diuretic effects and impact on the renin-angiotensin-aldosterone system of furosemide in healthy dogs. , 2010, The Journal of veterinary medical science.

[11]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[12]  C. O'connor,et al.  Loop Diuretics in Acute Decompensated Heart Failure: Necessary? Evil? A Necessary Evil? , 2009, Circulation. Heart failure.

[13]  V. Hasselblad,et al.  Cardiorenal interactions: insights from the ESCAPE trial. , 2008, Journal of the American College of Cardiology.

[14]  E. Braunwald.  JACC: Cardiovascular Interventions: the end of the beginning. , 2008, JACC: Cardiovascular Interventions.

[15]  V. Hasselblad,et al.  Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE Trial , 2007, European journal of heart failure.

[16]  M. Haigney,et al.  Furosemide and the progression of left ventricular dysfunction in experimental heart failure. , 2004, Journal of the American College of Cardiology.

[17]  J. Burnett,et al.  Brain Natriuretic Peptide Enhances Renal Actions of Furosemide and Suppresses Furosemide-Induced Aldosterone Activation in Experimental Heart Failure , 2004, Circulation.

[18]  M. Domanski,et al.  Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). , 2003, Journal of the American College of Cardiology.

[19]  M. Givertz.  Manipulation of the renin-angiotensin system. , 2001, Circulation.

[20]  M. Guazzi,et al.  Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. , 1994, The American journal of medicine.

[21]  M. Guazzi,et al.  Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. , 1993, The American journal of medicine.

[22]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[23]  K. Swedberg,et al.  Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group. , 1990, The American journal of cardiology.

[24]  P. Poole‐Wilson,et al.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. , 1987, British heart journal.

[25]  J. Cohn,et al.  Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.